Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max M Wattenberg

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The Journal of Experimental Medicine|May 27, 2020
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesisJeffrey H Lin, Austin P Huffman, Max M Wattenberg, et al.
British Journal of Cancer|December 3, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M Wattenberg, Daniella Asch, Shun Yu, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Nature Communications|October 10, 2023
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in miceStacy K Thomas, Max M Wattenberg, Shaanti Choi-Bose, et al.
Nature Immunology|April 19, 2024
Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteinsMeredith L Stone, Jesse Lee, Jae W Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
Science Immunology|November 17, 2023
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1Max M Wattenberg, Heather Coho, Veronica M Herrera, et al.
Molecular Cancer Therapeutics|December 3, 2020
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular CarcinomaKim A Reiss, Max M Wattenberg, Nevena Damjanov, et al.
Gastroenterology|January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal AdenocarcinomaMax M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Experimental Medicine|May 27, 2020
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesisJeffrey H Lin, Austin P Huffman, Max M Wattenberg, et al.
British Journal of Cancer|December 3, 2019
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutationMax M Wattenberg, Daniella Asch, Shun Yu, et al.
Scientific Reports|January 31, 2026
Sequential platinum and PARP Inhibition enhances PD1 immunotherapy efficacy in murine Brca2 mutated pancreatic cancerJohn C McVey, Max M Wattenberg, Heather Coho, et al.
Nature Communications|October 10, 2023
Kupffer cells prevent pancreatic ductal adenocarcinoma metastasis to the liver in miceStacy K Thomas, Max M Wattenberg, Shaanti Choi-Bose, et al.
Nature Immunology|April 19, 2024
Hepatocytes coordinate immune evasion in cancer via release of serum amyloid A proteinsMeredith L Stone, Jesse Lee, Jae W Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2021
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A Reiss, Rosemarie Mick, Mark H O'Hara, et al.
Science Immunology|November 17, 2023
Cancer immunotherapy via synergistic coactivation of myeloid receptors CD40 and Dectin-1Max M Wattenberg, Heather Coho, Veronica M Herrera, et al.
Molecular Cancer Therapeutics|December 3, 2020
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular CarcinomaKim A Reiss, Max M Wattenberg, Nevena Damjanov, et al.
Gastroenterology|January 20, 2024
Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal AdenocarcinomaMax M Wattenberg, Sarah Colby, Ignacio Garrido-Laguna, et al.
Pageof 2